Financials
| Proposed Cancellation | Mar. 28, 2024 |
| Half-year Report | Dec. 07, 2023 |
| Trading Update | Nov. 14, 2023 |
| Trading Update | Sep. 07, 2023 |
| Final Results | Jul. 31, 2023 |
| Trading Update and Board Changes | Apr. 27, 2023 |
| Interim results and Investor Presentation | Dec. 12, 2022 |
Proxies
| Result of AGM | Sep. 13, 2023 |
| Result of AGM | Sep. 22, 2022 |
| Result of AGM | Oct. 20, 2021 |
| Result of AGM | Nov. 13, 2020 |
| AGM Statement | Nov. 13, 2020 |
| Annual General Meeting – update on arrangements | Nov. 06, 2020 |
| Result of AGM | Nov. 14, 2019 |
Ownership Update
| Holding(s) in Company | Apr. 15, 2024 |
| Holding(s) in Company | Apr. 08, 2024 |
| Director Dealing | Apr. 02, 2024 |
| Holding(s) in Company | Nov. 09, 2023 |
| Director Dealing | Sep. 08, 2023 |
| Director Dealing | May. 24, 2023 |
| Director Dealing | Apr. 28, 2023 |
Announcements
| Secondary Trading on Asset Match | Apr. 29, 2024 |
| Results of General Meeting | Apr. 22, 2024 |
| Launch of PROCESSUS® Instrument Decontamination | Nov. 14, 2023 |
| Board Changes | Sep. 27, 2023 |
| Board Appointment | Sep. 07, 2023 |
| Launch of CHEMGENE MEDLAB into human healthcare | Aug. 29, 2023 |
| Investor Presentation via Investor Meet Company | Aug. 23, 2023 |